Suppr超能文献

4-(β-D-呋喃核糖基)氨基苯5'-磷酸合酶的作用机制,该酶是甲蝶呤生物合成途径中的关键酶。

Mechanism of 4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate synthase, a key enzyme in the methanopterin biosynthetic pathway.

作者信息

Dumitru Razvan V, Ragsdale Stephen W

机构信息

Department of Biochemistry, Beadle Center, University of Nebraska, Lincoln, Nebraska 68588-0664, USA.

出版信息

J Biol Chem. 2004 Sep 17;279(38):39389-95. doi: 10.1074/jbc.M406442200. Epub 2004 Jul 15.

Abstract

The first committed step in methanopterin biosynthesis is catalyzed by 4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate (RFA-P) synthase. Unlike all known phosphoribosyltransferases, beta-RFA-P synthase catalyzes the unique formation of a C-riboside instead of an N-riboside in the condensation of p-aminobenzoic acid (pABA) and 5-phospho-alpha-D-ribosyl-1-pyrophosphate (PRPP) to produce 4-(beta-D-ribofuranosyl)aminobenzene 5'-phosphate (beta-RFA-P), CO(2), and inorganic pyrophosphate (PP(i)). Here we report the successful cloning, active overexpression in Escherichia coli, and purification of this homodimeric enzyme containing two 36.2-kDa subunits from the methanogen Methanococcus jannaschii. Steady-state initial velocity and product inhibition kinetic studies indicate an ordered Bi-Ter mechanism involving binding of PRPP, then pABA, followed by release of the products CO(2), then beta-RFA-P, and finally PP. The Michaelis parameters are as follows: K(m)pABA, 0.15 mm; K(m)PRPP, 1.50 mm; V(max), 375 nmol/min/mg; k(cat), 0.23 s(-1). CO(2) showed uncompetitive inhibition, K(i) = 0.990 mm, under varied PRPP and saturated pABA, and a mixed type of inhibition, K(1) = 1.40 mm and K = 3.800 mm, under varied pABA and saturated PRPP. RFA-P showed uncompetitive inhibition, K(i) = 0.210 mm, under varied PRPP and saturated pABA, and again uncompetitive, K(i) = 0.300 mm, under saturated PRPP and varied pABA. PP(i) exhibits competitive inhibition, K(i) = 0.320 mm, under varied PRPP and saturated pABA, and a mixed type of inhibition, K(1) = 0.60 mm and K(2) = 1.900 mm, under saturated PRPP and varied pABA. Synthase lacks any chromogenic cofactor, and the presence of pyridoxal phosphate and the mechanistically related pyruvoyl cofactors has been strictly excluded.

摘要

甲蝶呤生物合成的首个关键步骤由4-(β-D-呋喃核糖基)氨基苯5'-磷酸(RFA-P)合酶催化。与所有已知的磷酸核糖基转移酶不同,β-RFA-P合酶在对氨基苯甲酸(pABA)和5-磷酸-α-D-核糖基-1-焦磷酸(PRPP)缩合形成4-(β-D-呋喃核糖基)氨基苯5'-磷酸(β-RFA-P)、CO₂和无机焦磷酸(PP(i))的过程中,催化形成C-核糖苷而非N-核糖苷。在此,我们报告了成功克隆来自嗜压甲烷球菌的这种含有两个36.2 kDa亚基的同二聚体酶,并在大肠杆菌中实现活性过量表达及纯化。稳态初始速度和产物抑制动力学研究表明其为有序的双底物-双产物机制,即先结合PRPP,然后是pABA,接着释放产物CO₂,再释放β-RFA-P,最后释放PP。米氏参数如下:K(m)pABA为0.15 mM;K(m)PRPP为1.50 mM;V(max)为375 nmol/min/mg;k(cat)为0.23 s⁻¹。在PRPP浓度变化且pABA饱和时,CO₂表现出非竞争性抑制,K(i)=0.990 mM;在pABA浓度变化且PRPP饱和时,CO₂表现出混合型抑制,K₁=1.40 mM,K₂=3.800 mM。在PRPP浓度变化且pABA饱和时,RFA-P表现出非竞争性抑制,K(i)=0.210 mM;在PRPP饱和且pABA浓度变化时,RFA-P再次表现出非竞争性抑制,K(i)=0.300 mM。在PRPP浓度变化且pABA饱和时,PP(i)表现出竞争性抑制,K(i)=0.320 mM;在PRPP饱和且pABA浓度变化时,PP(i)表现出混合型抑制,K₁=0.60 mM,K₂=1.900 mM。该合酶缺乏任何生色辅因子,并且已严格排除磷酸吡哆醛和机制相关的丙酮酰辅因子的存在。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验